Tri-Institutional
PhD Program Chemical Biology
The Tri-Institutional Ph.D. Program in Chemical Biology was established in 2001 as one of the first graduate programs in the world to focus on research and training at the interface of chemistry and biology. The program is a collaborative offering of three premier New York City institutions, Weill Cornell Medical College, The Rockefeller University, and the Memorial Sloan Kettering Cancer Center. Located adjacent to one another in the heart of Manhattan’s Upper East Side, these three institutions combine to create a unique university environment and provide unparalleled scientific opportunities to the next generation of leaders in chemical biology.
TPCB students are actively engaged in forefront research, mentored by internationally-recognized faculty members. Students choose from a broad range of chemical biology research areas based on their skills and interests, from the organic synthesis of bioactive small molecules to mechanistic investigations of macromolecules, to dissection of cellular processes using chemical probes, to in vivo evaluation of novel therapeutics. As a result of these exceptionally rich opportunities and the program’s emphasis on laboratory research, our students maintain an impressive publication record in leading scientific journals, with an average of five papers per graduate!
At TPCB, students will find outstanding resources for all phases of their training, including state-of-the-art research laboratories, core facilities, and collaborative research centers, as well as courses and seminars created specifically for TPCB students, access to additional courses at neighboring institutions in NYC, and opportunities to attend vibrant lecture series featuring world-class scientists. The program is also supported by a prestigious NIH Chemistry-Biology Interface T32 Training Grant.
Fall deadline
December
Department websites










